Recent Advances in Chemical Tools for the Regulation and Study of Protein Lysine Methyltransferases

DOI Web Site Web Site Web Site PubMed 129 References
  • Tomoya Hirano
    Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku Tokyo 101-0062 Japan
  • Shuichi Mori
    Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku Tokyo 101-0062 Japan
  • Hiroyuki Kagechika
    Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku Tokyo 101-0062 Japan

Search this article

Description

<jats:title>Abstract</jats:title><jats:p>Protein lysine methyltransferases (PKMTs) are epigenetic regulators that modulate gene transcription and physiological functions by catalyzing the post‐translational methylation of specific lysine residues of substrate proteins, such as histones. They are considered to be candidate drugs for the treatment of various diseases, including acute myeloid leukemia, and in the past decade, potent and selective inhibitors of individual PKMTs have been developed. Some are currently under clinical trial. In this review, we will focus on some breakthrough PKMT inhibitors, and discuss chemistry‐based methods available for elucidation of the physiological functions of PKMTs and methylated proteins.</jats:p>

Journal

References(129)*help

See more

Related Projects

See more

Keywords

Report a problem

Back to top